Device / Technology News

RSS

New AI algorithm accurately and quickly diagnoses idiopathic pulmonary fibrosis

A Nagoya University research group has developed an AI algorithm that accurately and quickly diagnoses idiopathic pulmonary fibrosis, a lung disease. The algorithm makes its diagnosis based only on information from non-invasive examinations, including lung images and medical information collected during daily medical care.

28 Jul 2022

New technology converts discarded bullfrog skin into wound healing products

A new clinical-grade collagen made from discarded bullfrog skin is leapfrogging from the lab bench to clinics soon.

27 Jul 2022

Study shows the efficacy of Yoga of Immortals mobile app for urinary incontinence

People with loss of urinary control who used the Yoga of Immortals mobile app – a globally used app that combines specific yogic postures in the Sanatan tradition with breathing exercises, sound therapy and meditation – found significant improvement in the frequency and severity of urine leaks at four weeks of practice, according to a Rutgers study.

26 Jul 2022

New AI technology may aid in the discovery of therapeutic agents for neurodegenerative disorders

A research group from Nagoya University in Japan has developed an artificial intelligence for analyzing cell images that uses machine learning to predict the therapeutic effect of drugs.

25 Jul 2022

New method uses drones to quickly deliver at-home COVID-19 diagnostic tests

Researchers at the Texas A&M University School of Public Health have developed a new COVID-19 test distribution method that uses drones to quickly deliver at-home diagnostic tests to individuals who suspect they have COVID-19.

25 Jul 2022

New robotic technology for neuroendovascular surgery could mean safer and more efficient procedures

Stroke surgery and other neuroendovascular procedures could be made safer and easier through robotics, according to research presented today at the Society of NeuroInterventional Surgery's (SNIS) 19th Annual Meeting.

25 Jul 2022

Using CRISPR technology to successfully prevent and treat SARS-CoV-2 infections

In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.

25 Jul 2022

New RT-PCR platform gives results faster than other COVID-19 tests on the market

For more than 30 years, polymerase chain reaction (PCR) has been the gold standard in molecular diagnostic testing, detecting genetic material, such as those from a virus or from human DNA.

25 Jul 2022

MolGen showcases its lab automation solutions at AACC in Chicago

MolGen B.V. of Veenendaal (NL), a global solutions provider of hardware, reagents, consumables, software and service for human and animal diagnostics, the agriculture and biotech industries, participates in the American Association for Clinical Chemistry Fair (AACC) in Chicago on July 24th - 28th, 2022.

From AgriGenX 25 Jul 2022

New research may lead to early diagnosis of devastating mental health conditions

New research by Georgia State University's TReNDS Center may lead to early diagnosis of devastating conditions such as Alzheimer's disease, schizophrenia and autism - in time to help prevent and more easily treat these disorders.

22 Jul 2022

Wireless biochemical sensor may use biomarkers in sweat to detect changes in a person's health

Researchers have successfully tested a device that may one day use the chemical biomarkers in sweat to detect changes in a person's health.

22 Jul 2022

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

As the BA.5 omicron variant continues to spread, health experts are increasingly preparing for a future in which such COVID-19 variants emerge, surge and recede similar to seasonal flu.

21 Jul 2022

New AI software can create proteins that may be useful as vaccines, cancer treatments

Scientists have developed artificial intelligence software that can create proteins that may be useful as vaccines, cancer treatments, or even tools for pulling carbon pollution out of the air.

21 Jul 2022

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

A sensor identifies misfolded protein biomarkers in the blood. This offers a chance to detect Alzheimer's disease before any symptoms occur. Researchers intend to bring it to market maturity.

21 Jul 2022

Researchers develop new protocol for using robotic pets with older dementia patients

You might think it was a typical therapy session at a long-term care facility. In a quiet room, a therapist sets down a pet carrier, brings out a cat, and sets it on a resident's lap.

20 Jul 2022

Wearable activity trackers are effective in increasing physical activity and improving health

New findings from Australian researchers have endorsed what millions of people around the world believe: fitness trackers, pedometers and smart watches motivate us to exercise more and lose weight.

20 Jul 2022

Machine learning models help forecast immunotherapy response from gut microbiomes

A new research paper was published in Oncotarget on July 19, 2022, entitled, "Predicting cancer immunotherapy response from gut microbiomes using machine learning models."

20 Jul 2022

Influenza surveillance systems may have helped detect early signs of COVID-19 pandemic

Outliers in the number of cases of influenza-like illness (ILI) that tested negative for influenza were present in global influenza surveillance networks early in the COVID-19 pandemic, an average of 13.3 weeks before the first reported COVID-19 peaks in 16 of the 28 countries included in a new study publishing July 19th in PLOS Medicine by Natalie Cobb of University of Washington, US, and colleagues.

20 Jul 2022

CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities

State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for Organ-on-a-Chip research services.

From CN Bio 19 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 19 Jul 2022

Device / Technology News

New AI algorithm accurately and quickly diagnoses idiopathic pulmonary fibrosis

New technology converts discarded bullfrog skin into wound healing products

Study shows the efficacy of Yoga of Immortals mobile app for urinary incontinence

New AI technology may aid in the discovery of therapeutic agents for neurodegenerative disorders

New method uses drones to quickly deliver at-home COVID-19 diagnostic tests

New robotic technology for neuroendovascular surgery could mean safer and more efficient procedures

Using CRISPR technology to successfully prevent and treat SARS-CoV-2 infections

New RT-PCR platform gives results faster than other COVID-19 tests on the market

MolGen showcases its lab automation solutions at AACC in Chicago

New research may lead to early diagnosis of devastating mental health conditions

Wireless biochemical sensor may use biomarkers in sweat to detect changes in a person's health

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

New AI software can create proteins that may be useful as vaccines, cancer treatments

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

Researchers develop new protocol for using robotic pets with older dementia patients

Wearable activity trackers are effective in increasing physical activity and improving health

Machine learning models help forecast immunotherapy response from gut microbiomes

Influenza surveillance systems may have helped detect early signs of COVID-19 pandemic

CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News